Starvaggi, J., Chio, C. D., Lang, J., Belgiovine, V., Trisciuzzi, D., Previti, S., . . . Ettari, R. (2026). Development of novel proline- and pipecolic acid-based allosteric inhibitors of dengue and Zika virus NS2B/NS3 protease. Pharmaceuticals, 19(1), . https://doi.org/10.3390/ph19010024
Chicago Style (17th ed.) CitationStarvaggi, Josè, et al. "Development of Novel Proline- and Pipecolic Acid-based Allosteric Inhibitors of Dengue and Zika Virus NS2B/NS3 Protease." Pharmaceuticals 19, no. 1 (2026). https://doi.org/10.3390/ph19010024.
MLA (9th ed.) CitationStarvaggi, Josè, et al. "Development of Novel Proline- and Pipecolic Acid-based Allosteric Inhibitors of Dengue and Zika Virus NS2B/NS3 Protease." Pharmaceuticals, vol. 19, no. 1, 2026, https://doi.org/10.3390/ph19010024.